Author:
Crone Steven A.,Zhao You-Yang,Fan Lian,Gu Yusu,Minamisawa Susumu,Liu Yang,Peterson Kirk L.,Chen Ju,Kahn Ronald,Condorelli Gianluigi,Jr John Ross,Chien Kenneth R.,Lee Kuo-Fen
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference37 articles.
1. Olayioye, M.A., Neve, R.M., Lane, H.A. & Hynes, N.E. The Erb signaling network: receptor heterodimerization in development and cancer. EMBO 19, 3159–3167 (2000).
2. Klapper, L., Kirschbaum, M.H., Sela, M. & Yarden, Y. Biochemical and clinical implication of the ErbB/HER signaling network of growth factor receptors. Adv. Cancer Res. 77, 25–79 (2000).
3. Hynes, N.E. & Stern, D.F. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochem. Biophys. Acta 1198, 165–184 (1994).
4. Slamon, D. et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. New Engl. J. Med. 344, 783–792 (2001).
5. Baselga, J. Current and planned clinical trials with trastuzumab (Herceptin). Sem. Oncol. 27, 27–32 (2000).
Cited by
734 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献